Stride has raised $6.1M in seed funding to build out what it calls the UK's first digital home for health optimisation. The round drew backing from Arāya Ventures, Better Ventures, Morgan Stanley Inclusive & Sustainable Ventures, and Innovate UK.
The company combines DNA, blood, and microbiome testing with expert coaching, supplements, and ePharmacy services, turning more than 500 biomarkers into steps that adapt as a user's biology changes. Its pitch is aimed at people who are guessing about their health and want to move from reactive to proactive.















